|
| Exchange Received Time 14/04/2017 16:18:11 Exchange Disseminated Time 14/04/2017 16:18:16 Time Taken 00:00:05 | | CIN : L74899DL1978PLC009181 The National Sto Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051. BSE Limited Corporate Relationship Department Pherojbhoy Jeejeebhoy Tower Ist Floor, Dalal Street, Mumbai - 400 001. REF: JAGSONPAL PHARMACEUTICALS LIMITED SCRIPT CODE : JAGSNPHARM & 507789 SUB: STATEMENT OF INVESTOR COMPLAINTS FOR THE QUARTER ENDED 31.03.2017 Sir/Madam, Pursuant to the provision of Regulation 13(3) of SEBI (Listing Obligation and Disclosure requirements) Regulation 2015 please find below statement for the Investor Complaints for quarter ended 31.03.2017. Sr. No. Nature of complaints during the quarter ended on 31st March, 2017. Numbers 01 Complaints pending at the beginning of the quarter Nil 02 Complaints received during the quarter 05 03 Complaints disposed off during the quarter 05 04 Complaints remained unresolved at the end of quarter for JAGSONPAL PHARMACEUTICALS LIMITED R. K. KAPOOR COMPANY SECRETARY CUM COMPLIANCE OFFICER |
|
|